Loading...
XJPX8086
Market cap1.54bUSD
Dec 27, Last price  
1,493.50JPY
1D
0.30%
1Q
5.18%
Jan 2017
16.86%
Name

Nipro Corp

Chart & Performance

D1W1MN
XJPX:8086 chart
P/E
21.93
P/S
0.42
EPS
68.11
Div Yield, %
1.24%
Shrs. gr., 5y
0.25%
Rev. gr., 5y
6.59%
Revenues
586.79b
+7.63%
192,320,000,000206,801,000,000184,362,000,000172,113,000,000175,944,000,000177,829,000,000195,942,000,000212,013,000,000241,020,000,000300,752,000,000325,084,000,000366,650,000,000359,699,000,000395,397,000,000426,399,000,000442,516,000,000455,559,000,000494,789,000,000545,199,000,000586,785,000,000
Net income
11.11b
+142.87%
4,518,000,0004,512,000,0008,555,000,0004,454,000,0004,530,000,0007,252,000,0002,455,000,0004,585,000,00010,231,000,0002,861,000,00012,470,000,00019,718,000,00011,346,000,00011,829,000,00012,136,000,000-12,281,000,00014,209,000,00013,455,000,0004,574,000,00011,109,000,000
CFO
72.94b
+601.65%
17,375,000,0006,701,000,00014,488,000,0009,675,000,00018,851,000,00026,240,000,00021,799,000,00015,486,000,00022,593,000,00021,552,000,00027,981,000,00029,934,000,00033,472,000,00041,046,000,00041,362,000,00037,246,000,00066,093,000,00068,214,000,00010,395,000,00072,936,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 06, 2025

Profile

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.
URL
https://www.nipro.co.jp/
IPO date
Feb 01, 1987
Employees
38,770
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
586,785,000
7.63%
545,199,000
10.19%
494,789,000
8.61%
Cost of revenue
567,108,000
529,921,000
473,473,000
Unusual Expense (Income)
NOPBT
19,677,000
15,278,000
21,316,000
NOPBT Margin
3.35%
2.80%
4.31%
Operating Taxes
7,049,000
10,843,000
8,177,000
Tax Rate
35.82%
70.97%
38.36%
NOPAT
12,628,000
4,435,000
13,139,000
Net income
11,109,000
142.87%
4,574,000
-66.01%
13,455,000
-5.31%
Dividends
(3,025,000)
(4,247,000)
(5,224,000)
Dividend yield
1.34%
2.26%
2.94%
Proceeds from repurchase of equity
(34,000)
19,729,000
118,961,000
BB yield
0.02%
-10.52%
-66.85%
Debt
Debt current
195,406,000
157,201,000
162,642,000
Long-term debt
470,341,000
478,435,000
431,721,000
Deferred revenue
9,142,000
6,014,000
6,737,000
Other long-term liabilities
40,801,000
26,296,000
8,898,000
Net debt
533,034,000
484,780,000
429,115,000
Cash flow
Cash from operating activities
72,936,000
10,395,000
68,214,000
CAPEX
(94,203,000)
(84,835,000)
(79,803,000)
Cash from investing activities
(87,075,000)
(71,737,000)
(78,434,000)
Cash from financing activities
22,142,000
43,077,000
10,297,000
FCF
(41,983,000)
(111,499,000)
(13,981,000)
Balance
Cash
99,667,000
89,678,000
95,342,000
Long term investments
33,046,000
61,178,000
69,906,000
Excess cash
103,373,750
123,596,050
140,508,550
Stockholders' equity
280,535,000
422,091,000
378,930,000
Invested Capital
833,759,250
751,920,950
634,316,450
ROIC
1.59%
0.64%
2.12%
ROCE
2.10%
1.74%
2.75%
EV
Common stock shares outstanding
184,075
184,075
173,786
Price
1,225.50
20.26%
1,019.00
-0.49%
1,024.00
-23.41%
Market cap
225,583,912
20.26%
187,572,425
5.40%
177,956,864
-18.39%
EV
795,740,912
877,379,425
790,015,864
EBITDA
78,549,000
64,021,000
67,480,000
EV/EBITDA
10.13
13.70
11.71
Interest
6,527,000
4,501,000
4,135,000
Interest/NOPBT
33.17%
29.46%
19.40%